Tertomotide hydrochloride

Tertomotide (GV1001) hydrochloride is a peptide vaccine composed of a 16-amino acid sequence from human telomerase reverse transcriptase (hTERT) . It exhibits neuroprotective properties and has potential for research in Alzheimer's disease.

C([C@@H](NC([C@H](CC1=CC=CC=C1)NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(=O)[C@H]2N(C([C@@H](NC([C@@H](NC([C@H](CCC(O)=O)N)=O)C)=O)CCCNC(=N)N)=O)CCC2)C)=O)CC(C)C)=O)CC(C)C)=O)[C@@H](C)O)=O)CO)=O)CCCNC(=N)N)=O)CC(C)C)=O)CCCNC(=N)N)=O)=O)[C@H](CC)C)(=O)N3[C@H](C(N[C@@H](CCCCN)C(O)=O)=O)CCC3.Cl